Latest Breaking News On - Dupilumab dupixent - Page 1 : comparemela.com

Biologics for Severe Asthma Present Opportunities for Pharmacists

Drug therapy workups may reveal candidates for immune therapy and provide chance for interventions.

United-states
United-kingdom
British
Benralizumab-fasenra
Omalizumab-xolair
Regeneron-sanofi
Mepolizumab-nucala
Reslizumab-cinqair
Dupilumab-dupixent
Teva-respiratory
Global-asthma-initiative
Global-initiative-for-asthma

Dementia Scotland: Blood test could predict dementia up to 15 years before diagnosis, study shows

Dementia Scotland: Blood test could predict dementia up to 15 years before diagnosis, study shows
scotsman.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from scotsman.com Daily Mail and Mail on Sunday newspapers.

United-kingdom
China
Britons
British
Scotland
Scott-muir
Cabozantinib-cabometyx
Dupilumab-dupixent
Richard-oakley
Jianfeng-feng
Simon-dawson
Nilima-marshall

Q&A: Improved outcomes anticipated with dupilumab for children with EoE

Q&A: Improved outcomes anticipated with dupilumab for children with EoE
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Dupilumab-dupixent
Evans-dellon
School-of-medicine
Esophageal-diseases

Gastroenterology Month in Review: January 2024

Our January 2024 Month in Review spotlights the FDA approval of a new indication of dupilumab (Dupixent) for pediatric eosinophilic esophagitis, new clinical trial data, and research about the prevention and management of IBD.

Evan-dellon
Dupilumab-dupixent
Julie-khlevner
Drug-administration
University-of-north-carolina-chapel-hill
Contemporary-pediatric
Esophageal-diseases
North-carolina-chapel-hill
Pediatric-gastrointestinal-motility-center
Columbia-university-medical-center
Ibd
Inflammatory-bowel-disease

FDA Approves Dupilumab to Treat EoE for Children Under 12 Years

The expanded indication makes dupilumab the only approved treatment for eosinophilic esophagitis (EoE) in this age group.

United-states
American
Dupilumab-dupixent
Georged-yancopoulos
Naimish-patel
Young
Head-of-global-development
Pediatric-eoe
Symptom-questionnaire-caregiver
Global-development
American-journal
Eosinophilic-esophagitis